SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.50 (0.84%)
Bid:
59.00
Ask:
61.00
Spread: 2.00 (3.39%)
Market Cap: £47.29m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Pre-close Trading Update

23 Sep 2020 07:00

RNS Number : 7760Z
Hardide PLC
23 September 2020
 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

23 September 2020

 

Hardide plc

("Hardide" or "the Group" or "the Company")

 

Pre-close Trading Update

 

Hardide plc (AIM: HDD), the developer and provider of advanced surface coating technology, is pleased to provide an update on trading for the financial year ending 30 September 2020.

 

The Group expects (subject to audit and year-end adjustments) to report revenues of £4.7 million and an EBITDA loss of c.£0.5 million. This is in line with the Trading Update issued on 16 July 2020. Cash at bank is expected to be c.£2.7 million and there are capital commitments of c.£0.5 million remaining to fully complete the investment in the UK site relocation.

 

Production has continued uninterrupted at both the UK and US sites throughout the COVID-19 pandemic, with significant emphasis being placed on health and safety measures to protect staff and contractors.

 

The relocation of the business to the new site at Longlands Road, Bicester is now complete, on schedule and at projected cost. After delays due to travel restrictions, the large reactor has now been installed and commissioned, which completes the installation of all new equipment at the facility. This reactor, together with the new large pre-treatment line, increases considerably the size range of components that can be coated. One Airbus-approved reactor is still operational at the Wedgwood Road site and this will remain in place until the Longlands Road site is fully approved by Airbus. In addition to the developments in the UK, a fourth reactor has been installed at the Martinsville, Virginia facility making a total of nine reactors in the Group.

 

The extensive process of Airbus' qualification for the new site is progressing well and on schedule to be completed in early 2021. Orders are now starting to be received for the Airbus components that have been approved previously and shortly further parts are due to be approved by Airbus.

The Group previously reported the impact on its current year revenue from a delay in receiving a major oil and gas project order caused by the COVID-19 pandemic. Hardide is pleased to report that this order has now been received and will give a positive start to the first quarter of the new financial year. Generally, there has been a reduction in demand from oil and gas customers in this current second half as the global economy has slowed. However, it is pleasing that demand from customers in flow control and precision engineering has not been significantly affected.

Multiple test programmes for new applications are progressing strongly with customers in various sectors and therefore present encouraging prospects for new business in the 2020-21 financial year. Looking beyond the disruption of the present COVID-19 pandemic, the Board of Hardide believes there are strong grounds for expecting a return to increasing demand and remain positive about the longer-term growth of the Company.

 

The Group expects to report its preliminary results for the year to 30 September 2020 on or around 7 December 2020.

 

Enquiries:

 

Hardide plc

Robert Goddard, Non-Executive Chairman

Philip Kirkham, CEO

Jackie Robinson, Communications Manager

 

 

Tel: +44 (0) 1869 353830

 

IFC Advisory

Graham Herring / Tim Metcalfe / Florence Chandler

 

Tel: +44 (0) 20 3934 6630

 

finnCap - Nominated Adviser and Joint Broker

Henrik Persson / Matthew Radley (corporate finance)

Richard Chambers (ECM)

 

Allenby Capital- Joint Broker

Jeremy Porter (Corporate Finance)

Tony Quirke (Sales)

 

Tel: +44 (0) 20 7220 0500

 

 

Tel: +44 (0) 20 3328 5656

Notes to editors:

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining, in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency. Customers include leading companies operating in oil and gas exploration and production, valve and pump manufacturing, precision engineering and aerospace industries.

www.hardide.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTELLFLBKLXBBE
Date   Source Headline
1st Jun 20263:35 pmRNSHolding(s) in Company
27th May 20267:00 amRNSSignificant further order intake North America
21st May 20267:00 amRNSInterim Statement
5th May 20266:00 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSNew Order Intake and Notice of Interim Results
24th Mar 20264:30 pmRNSResult of AGM
24th Mar 20264:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAGM Trading Statement
20th Mar 20265:05 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSNotice of AGM
17th Mar 20267:00 amRNSNotice of AGM
11th Mar 202610:09 amRNSHolding(s) in Company
11th Mar 202610:09 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSFurther significant North American order intake
13th Feb 202612:03 pmRNSHolding(s) in Company
11th Feb 202611:35 amRNSDirector Dealings
10th Feb 202612:48 pmRNSGrant of Executive Share Options
3rd Feb 20267:00 amRNSSignificant New Order in North America
29th Jan 202611:17 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSAnnual results to 30 September 2025
12th Jan 20267:00 amRNSNotice of Results
1st Dec 20253:03 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSSignificant Orders from a Major New Customer
7th Nov 20258:53 amRNSHolding(s) in Company
24th Oct 20255:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSYear End Trading Update
28th May 20253:00 pmRNSDirector Dealings
27th May 20252:48 pmRNSDirector Dealings
20th May 20257:00 amRNSInterim Statement
18th Mar 20253:30 pmRNSResult of AGM
18th Mar 20257:00 amRNSAGM Trading Statement
4th Feb 20257:00 amRNSDirector Dealings
29th Jan 20257:00 amRNSAnnual results for year ended 30 September 2024
15th Jan 202510:00 amRNSNotice of Results
27th Dec 20247:00 amRNSGrant of Options and Issue of Shares
18th Dec 20247:00 amRNSNew Aerospace Supply Agreement
3rd Dec 20247:00 amRNSBoard Changes
21st Oct 20247:00 amRNSYear End Trading Update
18th Jun 20247:00 amRNSBoard Change and Appointment of Sole Broker
22nd May 20247:01 amRNSInterim Statement
22nd May 20247:00 amRNSAnnouncement of new Chief Executive Officer
8th May 20247:00 amRNSNotice of Results
1st May 202410:27 amRNSHolding(s) in Company
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.